Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial.
Saved in:
| Title: | Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial. |
|---|---|
| Authors: | Ostrominski JW; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Mc Causland FR; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Desai AS; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Jhund PS; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Senni M; University of Milano-Bicocca ASST Papa Giovanni XXIII Hospital, Bergamo, Italy., Shah SJ; Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Voors AA; University Medical Center Groningen, Groningen, the Netherlands., Zannad F; Université de Lorraine, Inserm Clinical Investigation Centre, CHU, Nancy, France., Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA., Schloemer P; Bayer, Research and Development, Pharmaceuticals, Berlin, Germany., Brinker M; Bayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany., Scheerer MF; Bayer AG, Global Medical Affairs, Berlin, Germany., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: ssolomon@bwh.harvard.edu., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. |
| Source: | JACC. Heart failure [JACC Heart Fail] 2026 Jan; Vol. 14 (1), pp. 102439. Date of Electronic Publication: 2025 Apr 02. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
